Abstract
Abstract
There is increasing interest in using helium ions for radiotherapy, complementary to protons and carbon ions. A large number of patients were treated with 4He ions in the US heavy ion therapy project and novel 4He ion treatment programs are under preparation, for instance in Germany and Japan. 3He ions have been proposed as an alternative to 4He ions because the acceleration of 3He is technically less difficult than 4He. In particular, beam contaminations have been pointed out as a potential safety issue for 4He ion beams. This motivated a series of experiments with 3He ion beams at Gesellschaft für Schwerionenforschung (GSI), Darmstadt. Measured 3He Bragg curves and fragmentation data in water are presented in this work. Those experimental data are compared with FLUKA Monte Carlo simulations. The physical characteristics of 3He ion beams are compared to those of 4He, for which a large set of data became available in recent years from the preparation work at the Heidelberger Ionenstrahl-Therapiezentrum (HIT). The dose distributions (spread out Bragg peaks, lateral profiles) that can be achieved with 3He ions are found to be competitive to 4He dose distributions. The effect of beam contaminations on 4He depth dose distribution is also addressed. It is concluded that 3He ions can be a viable alternative to 4He, especially for future compact therapy accelerator designs and upgrades of existing ion therapy facilities.
Subject
Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology
Reference65 articles.
1. Relocation of the helium ion radiotherapy program from the 184″ synchrocyclotron to the BEVALAC;Alonso,1989
2. Developments of the nuclear reaction and fragmentation models in FLUKA for ion collisions at therapeutic energies;Aricò,2019
3. HICAT—the Heavy Ion Cancer Therapy accelerator facility for the clinic in Heidelberg;Bär;Technical Description,2000
4. Overview of the FLUKA code;Battistoni;Ann. Nucl. Energy,2015
5. The FLUKA Code: an accurate simulation tool for particle therapy;Battistoni;Frontiers Oncol.,2016
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献